Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial
Titel:
Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial
Auteur:
Ray, Kausik K. Nicholls, Stephen J. Ginsberg, Henry D Johansson, Jan O. Kalantar-Zadeh, Kamyar Kulikowski, Ewelina Toth, Peter P. Wong, Norman Cummings, Jeffrey L. Sweeney, Michael Schwartz, Gregory G.